Richard B. Gaynor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Richard B. Gaynor has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Dmitri Ivanov
Center for Genomic Integrity, Institute for Basic Science, Ulsan, Republic of Korea
3 shared publications E Nee
University of Texas Southwestern Medical Center
2 shared publicationsFrançoise Bex
Divisions of Molecular Virology and Hematology-Oncology
2 shared publicationsJ Guo
2 shared publicationsJun Guo
From the Division of Hematology-Oncology, Department of Medicine, Harold Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 75235-8594
2 shared publicationsMin-Jean Yin
Department of Medicine, Division of Hematology-Oncology, Harold Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 75235-8594, USA
2 shared publications
Latest Publications
- Open Access
- 1 July 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (27) , 24331-24339
Regulation of IκB Kinase (IKK)γ/NEMO Function by IKKβ-mediated Phosphorylation
- 1 July 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (27) , 24331-24339
Open AccessRegulation of IκB Kinase (IKK)γ/NEMO Function by IKKβ-mediated Phosphorylation
- Open Access
- 1 February 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (6) , 4494-4500
Role of IKKγ/NEMO in Assembly of the IκB Kinase Complex
- 1 February 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (6) , 4494-4500
Open AccessRole of IKKγ/NEMO in Assembly of the IκB Kinase Complex
- Top Cited PapersOpen Access
- 15 January 2001
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (2) , 135-142
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
- 15 January 2001
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (2) , 135-142
Top Cited PapersOpen AccessTherapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
- Open Access
- 1 May 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (19) , 14752-14759
Analysis of Domains in the IKKα and IKKβ Proteins That Regulate Their Kinase Activity
- 1 May 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (19) , 14752-14759
Open AccessAnalysis of Domains in the IKKα and IKKβ Proteins That Regulate Their Kinase Activity
- 1 May 2000
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 20 (9) , 2970-2983
Domains in the SPT5 Protein That Modulate Its Transcriptional Regulatory Properties
SPT5 and its binding partner SPT4 regulate transcriptional elongation by RNA polymerase II. SPT4 and SPT5 are involved in both 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole (DRB)-mediated transcriptional inhibition and the activation of transcriptional elongation by the human immunodeficiency virus type 1 (HIV-1) Tat protein. Recent data suggest that P-TEFb, which is composed of CDK9 and cyclin T1, is also critical in regulating transcriptional elongation by SPT4 and SPT5. In this study, we analyze the domains of SPT5 that regulate transcriptional elongation in the presence of either DRB or the HIV-1 Tat protein. We demonstrate that SPT5 domains that bind SPT4 and RNA polymerase II, in addition to a region in the C terminus of SPT5 that contains multiple heptad repeats and is designated CTR1, are critical for in vitro transcriptional repression by DRB and activation by the Tat protein. Furthermore, the SPT5 CTR1 domain is a substrate for P-TEFb phosphorylation. These results suggest that C-terminal repeats in SPT5, like those in the RNA polymerase II C-terminal domain, are sites for P-TEFb phosphorylation and function in modulating its transcriptional elongation properties.
- 1 May 2000
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 20 (9) , 2970-2983
Domains in the SPT5 Protein That Modulate Its Transcriptional Regulatory Properties
SPT5 and its binding partner SPT4 regulate transcriptional elongation by RNA polymerase II. SPT4 and SPT5 are involved in both 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole (DRB)-mediated transcriptional inhibition and the activation of transcriptional elongation by the human immunodeficiency virus type 1 (HIV-1) Tat protein. Recent data suggest that P-TEFb, which is composed of CDK9 and cyclin T1, is also critical in regulating transcriptional elongation by SPT4 and SPT5. In this study, we analyze the domains of SPT5 that regulate transcriptional elongation in the presence of either DRB or the HIV-1 Tat protein. We demonstrate that SPT5 domains that bind SPT4 and RNA polymerase II, in addition to a region in the C terminus of SPT5 that contains multiple heptad repeats and is designated CTR1, are critical for in vitro transcriptional repression by DRB and activation by the Tat protein. Furthermore, the SPT5 CTR1 domain is a substrate for P-TEFb phosphorylation. These results suggest that C-terminal repeats in SPT5, like those in the RNA polymerase II C-terminal domain, are sites for P-TEFb phosphorylation and function in modulating its transcriptional elongation properties.
- Open Access
- 1 November 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (48) , 34417-34424
The Human T-cell Leukemia Virus Type-1 Tax Protein Regulates the Activity of the IκB Kinase Complex
- 1 November 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (48) , 34417-34424
Open AccessThe Human T-cell Leukemia Virus Type-1 Tax Protein Regulates the Activity of the IκB Kinase Complex
- 1 April 1999
- Published by Elsevier in Journal of Molecular Biology
- Vol. 288 (1) , 57-69
Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation
- 1 April 1999
- Published by Elsevier in Journal of Molecular Biology
- Vol. 288 (1) , 57-69
Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation
- 1 April 1999
- Published by Elsevier in Journal of Molecular Biology
- Vol. 288 (1) , 41-56
Cyclin T1 domains involved in complex formation with tat and TAR RNA are critical for tat-activation
- 1 April 1999
- Published by Elsevier in Journal of Molecular Biology
- Vol. 288 (1) , 41-56
Cyclin T1 domains involved in complex formation with tat and TAR RNA are critical for tat-activation
- 1 January 1999
- Vol. 7, 233-45
Regulation of NF-kappaB by the HTLV-1 Tax protein.
The Tax protein encoded by the human T-cell leukemia virus type 1 (HTLV-1) activates viral gene expression via the ATF/CREB pathway. Tax also induces a variety of cellular genes through activation of the transcription factor NF-kappaB. The ability of Tax to activate the NF-kappaB pathway plays an essential role in HTLV-1-induced cellular transformation. This review briefly summarizes the remarkable discoveries of the past several years that have greatly advanced our knowledge on signal-mediated activation of the NF-kappaB pathway. It highlights our current understanding of how viral agents like Tax modulate cellular signaling machinery to activate the NF-kappaB pathway.
- 1 January 1999
- Vol. 7, 233-45
Regulation of NF-kappaB by the HTLV-1 Tax protein.
The Tax protein encoded by the human T-cell leukemia virus type 1 (HTLV-1) activates viral gene expression via the ATF/CREB pathway. Tax also induces a variety of cellular genes through activation of the transcription factor NF-kappaB. The ability of Tax to activate the NF-kappaB pathway plays an essential role in HTLV-1-induced cellular transformation. This review briefly summarizes the remarkable discoveries of the past several years that have greatly advanced our knowledge on signal-mediated activation of the NF-kappaB pathway. It highlights our current understanding of how viral agents like Tax modulate cellular signaling machinery to activate the NF-kappaB pathway.
- Open Access
- 1 July 1998
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 18 (7) , 4221-4234
DNA-Dependent Protein Kinase Phosphorylation of IκBα and IκBβ Regulates NF-κB DNA Binding Properties
Regulation of the IκBα and IκBβ proteins is critical for modulating NF-κB-directed gene expression. Both IκBα and IκBβ are substrates for cellular kinases that phosphorylate the amino and carboxy termini of these proteins and regulate their function. In this study, we utilized a biochemical fractionation scheme to purify a kinase activity which phosphorylates residues in the amino and carboxy termini of both IκBα and IκBβ. Peptide microsequence analysis by capillary high-performance liquid chromatography ion trap mass spectroscopy revealed that this kinase was the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). DNA-PK phosphorylates serine residue 36 but not serine residue 32 in the amino terminus of IκBα and also phosphorylates threonine residue 273 in the carboxy terminus of this protein. To determine the biological relevance of DNA-PK phosphorylation of IκBα, murine severe combined immunodeficiency (SCID) cell lines which lack the DNA-PKcs gene were analyzed. Gel retardation analysis using extract prepared from these cells demonstrated constitutive nuclear NF-κB DNA binding activity, which was not detected in extracts prepared from SCID cells complemented with the human DNA-PKcs gene. Furthermore, IκBα that was phosphorylated by DNA-PK was a more potent inhibitor of NF-κB binding than nonphosphorylated IκBα. These results suggest that DNA-PK phosphorylation of IκBα increases its interaction with NF-κB to reduce NF-κB DNA binding properties.
- 1 July 1998
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 18 (7) , 4221-4234
Open AccessDNA-Dependent Protein Kinase Phosphorylation of IκBα and IκBβ Regulates NF-κB DNA Binding Properties
Regulation of the IκBα and IκBβ proteins is critical for modulating NF-κB-directed gene expression. Both IκBα and IκBβ are substrates for cellular kinases that phosphorylate the amino and carboxy termini of these proteins and regulate their function. In this study, we utilized a biochemical fractionation scheme to purify a kinase activity which phosphorylates residues in the amino and carboxy termini of both IκBα and IκBβ. Peptide microsequence analysis by capillary high-performance liquid chromatography ion trap mass spectroscopy revealed that this kinase was the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). DNA-PK phosphorylates serine residue 36 but not serine residue 32 in the amino terminus of IκBα and also phosphorylates threonine residue 273 in the carboxy terminus of this protein. To determine the biological relevance of DNA-PK phosphorylation of IκBα, murine severe combined immunodeficiency (SCID) cell lines which lack the DNA-PKcs gene were analyzed. Gel retardation analysis using extract prepared from these cells demonstrated constitutive nuclear NF-κB DNA binding activity, which was not detected in extracts prepared from SCID cells complemented with the human DNA-PKcs gene. Furthermore, IκBα that was phosphorylated by DNA-PK was a more potent inhibitor of NF-κB binding than nonphosphorylated IκBα. These results suggest that DNA-PK phosphorylation of IκBα increases its interaction with NF-κB to reduce NF-κB DNA binding properties.